Oxford Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Oxford Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,233	Closed	-$595K	–	2089
2019 Q2	$595K	Sell	10,233 -22,231	-68%	-$1.32M	0.01%	1198
2019 Q1	$2.27M	Buy	32,464 +27,600	+567%	+$2.05M	0.05%	513
2018 Q4	$313K	Sell	4,864 -65,268	-93%	-$4.58M	0.01%	1381
2018 Q3	$4.87M	Sell	70,132 -8,272	-11%	-$484K	0.1%	230
2018 Q2	$3.92M	Sell	78,404 -20,028	-20%	-$795K	0.08%	296
2018 Q1	$3.08M	Buy	+98,432	New	+$3.27M	0.07%	354
2017 Q4	–	Sell	-9,576	Closed	-$307K	–	1975
2017 Q3	$307K	Buy	+9,576	New	+$302K	0.01%	1333
2016 Q2	–	Sell	-27,794	Closed	-$688K	–	925
2016 Q1	$688K	Buy	27,794 +7,018	+34%	+$193K	0.02%	557
2015 Q4	$732K	Sell	20,776 -40,605	-66%	-$1.09M	0.02%	602
2015 Q3	$1.3M	Buy	+61,381	New	+$1.58M	0.04%	358
2015 Q1	–	Sell	-32,692	Closed	-$1.06M	–	795
2014 Q4	$1.06M	Buy	+32,692	New	+$1.06M	0.02%	464

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Oxford Asset Management's GHDX Position: Q3 2019 in Review

Oxford Asset Management sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 10,233 shares — an estimated $595K sold.

Oxford Asset Management first reported a position in GHDX in Q4 2014 and held it in 11 quarters. The position peaked at $4.87M in Q3 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

Oxford Asset Management reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
Oxford Asset Management sold 10,233 Genomic Health, Inc. shares in Q3 2019, an estimated $595K.
Oxford Asset Management first reported a position in Genomic Health, Inc. in Q4 2014 and held it in 11 quarters.
Oxford Asset Management's Genomic Health, Inc. position peaked at $4.87M in Q3 2018.
221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Oxford Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.